Abstract
Introduction
The epidemiology of primary immunodeficiencies (PID) is not well documented in Africa. The objective of this study was to describe the spectrum of PID at a tertiary paediatric centre in South Africa.
Methods
A retrospective study was conducted on 168 patients diagnosed with PID from 1983 to 2009.
Results
Over the study period, antibody deficiencies predominated (51%) followed by well-defined syndromes (24%). Common variable immunodeficiency was the commonest antibody deficiency. The mean age of diagnosis was 51 months overall but decreased significantly to 35 months over the last 9 years. Recurrent infections were the most common presenting complaint (74%). The overall mortality rate was 25% while combined immunodeficiencies accounted for 40% of the deaths.
Conclusions
The spectrum of PID in South Africa was similar to international trends. The declining mean age of diagnosis indicated improved recognition of PID. Future research should focus on identifying children with PID more effectively.
Similar content being viewed by others
References
Ballow M, Notarangelo L, Grimbacher B, Cunningham-Rundles C, Stein M, Helbert M, et al. Immunodeficiencies. Clin Exp Immunol. 2009;158(supp 1):14–22.
International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, et al. Primary immunodeficiencies. J Allergy Clin Immunol. 2009;124:1161–78.
Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European Internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157(supp 1):3–11.
Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101–8.
Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.
Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84(1):16–22.
Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18 year experience from a tertiary care center. J Clin Immunol. 2009;29:357–64.
Lee WI, Kuo ML, Huang JL, Lin SJ, CJ WU. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol. 2005;25:162–73.
Modell F, Puente D, Modell V. From genotype to phenotype: further studies measuring the impact of a physician education and public awareness campaign on early diagnosis and management of primary immunodeficiencies. Immunol Res. 2009;44:132–49.
Eley BS, Hughes J, Cooper M, Pienaar S, Beatty DW. Primary immunodeficiency at Red Cross War Memorial Children’s Hospital. S Afr Med J. 1997;87(12):1684–8.
Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29:343–51.
Bejaoui BM, Barbouche MR, Sassi A, Larguche B, Miladi N, Bouguerra A, et al. Primary immunodeficiency in Tunisia: study of 152 cases. Arch Pediatr. 1997;4(9):827–31.
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clin Immunol. 1999;93(3):190–7.
Eley BS, Hughes EJ, Cooper M, Pienaar S, Shaboodien G, Henderson H, Beatty DW. Primary immunodeficiency diseases in Cape Town. Abstract: K2.Mon.1.21/1; 11th International Congress of Immunology. Stockholm, Sweden, July 2001.
Pienaar S, Eley BS, Hughes J, Henderson HE. X-linked hyper IgM (HIGM1) in an African kindred: the first report from South Africa. BMC Pediatr. 2003;3(12).
Pienaar S, Eley BS, Beatty DW, Henderson HE. X-linked agammaglobulinaemia and the underlying genetics in two kindreds. J Pediatr Child Health. 2000;36:453–6.
CEREDIH -The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264–72.
Statistics South Africa: mid-year population estimates 2010. www.statssa.gov.sa (2010). Accessed 16 August 2010.
Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestation of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol. 2006;26:519–32.
Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340(7):508–16.
Antoine C, Müller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet. 2003;361(9357):553–60.
Acknowledgements
Dr. R. Naidoo is an infectious diseases fellow supported by PEPFAR/USAID through the ANOVA Health Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naidoo, R., Ungerer, L., Cooper, M. et al. Primary Immunodeficiencies: A 27-Year Review at a Tertiary Paediatric Hospital in Cape Town, South Africa. J Clin Immunol 31, 99–105 (2011). https://doi.org/10.1007/s10875-010-9465-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-010-9465-7